Hyoscine Butylbromide for Functional Abdominal Pain

Phase 2, randomised, double-blind trial in functional abdominal pain (FAP) comparing HBB 20mg with Placebo (2 arms). Primary endpoints: Change From Baseline in Intensity of Abdominal Pain Associated With Cramping Following Treatment Based on the Numeric Pain Rating Scale (NPRS) at 4 hours, Area Under the Curve (AUC) Calculated From the Responses to the Numeric Pain Rating Scale (NPRS) Scores at 4 hours and 5 more. Started Jun 2009; status: completed.